| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 130.909 | 121.383 | 137.711 | 202.895 | 238.722 | 346.742 | 405.986 | 439.681 | 496.352 | 533.313 |
| Total Income - EUR | 130.931 | 121.393 | 137.711 | 202.977 | 238.781 | 346.892 | 405.991 | 439.684 | 496.355 | 534.577 |
| Total Expenses - EUR | 125.755 | 128.593 | 124.058 | 176.499 | 228.065 | 318.171 | 367.660 | 406.139 | 455.421 | 500.966 |
| Gross Profit/Loss - EUR | 5.176 | -7.201 | 13.653 | 26.478 | 10.716 | 28.721 | 38.331 | 33.545 | 40.934 | 33.611 |
| Net Profit/Loss - EUR | 2.119 | -8.505 | 12.295 | 24.448 | 8.328 | 25.250 | 34.224 | 29.114 | 35.922 | 27.799 |
| Employees | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
Check the financial reports for the company - Farmacia Vialiv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 390 | 568 | 217 | 7 | 799 | 7.373 | 4.977 | 3.022 | 365 | 66.282 |
| Current Assets | 118.692 | 105.951 | 129.027 | 154.932 | 217.024 | 252.951 | 298.044 | 322.976 | 385.197 | 378.844 |
| Inventories | 47.487 | 43.984 | 44.401 | 57.710 | 82.758 | 101.456 | 143.966 | 162.346 | 212.132 | 255.252 |
| Receivables | 69.373 | 57.429 | 79.755 | 110.948 | 116.320 | 160.597 | 170.362 | 174.475 | 171.642 | 126.762 |
| Cash | 1.832 | 4.537 | 4.871 | -13.726 | 17.947 | -9.103 | -16.284 | -13.846 | 1.424 | -3.169 |
| Shareholders Funds | 63.844 | 54.687 | 66.057 | 89.293 | 95.893 | 119.325 | 150.903 | 180.486 | 215.860 | 231.526 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 55.238 | 51.832 | 63.187 | 65.647 | 121.931 | 140.999 | 152.118 | 145.512 | 169.702 | 213.600 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Vialiv S.r.l.